semaglutide pooping blood Semaglutide-Associated Ischemic Colitis in a Patient Without Traditional Risk Factors: A Case Report Can Ozempic (semaglutide) cause internal

Additionally, severe symptoms related to gallbladder problems should be monitored

Prescribing Information for Semaglutide injection

Gastrointestinal Very common (10% or more): Gastrointestinal adverse reactions (up to 73%), nausea (up to 44%), vomiting (up to 36%), diarrhea (up to 30%), constipation (up to 24.2%), abdominal pain (up to 20%) Common (1% to 10%): Dyspepsia, abdominal distension, eructation, flatulence, gastroenteritis, gastroesophageal reflux disease, gastritis, viral gastroenteritis, increased amylase, increased lipase, dry mouth, severe gastrointestinal adverse reactions, delayed gastric emptying Uncommon (0.1% to 1%): Acute pancreatitis, appendicitis Frequency not reported : Hemorrhoids, hiccups Postmarketing reports : Ileus, intestinal obstruction, severe constipation, hiccups, acute pancreatitis, necrotizing pancreatitis In clinical trials in adults using the subcutaneous injection for weight reduction, 73% of treated patients reported gastrointestinal adverse reactions, including severe reactions (4.1%)

Semaglutide is a medication used to manage weight and blood sugar, and it is not currently on the Medication Deferral List maintained by major blood and plasma donation organizations like the American Red Cross or CSL Plasma